Effects of Rivaroxaban on Vascular FMD in Patients With Stable Atherosclerotic Vascular Diseases
Clinical trial NCT06986369 · COMPLETED
Trial details
- NCT number
- NCT06986369
- Sponsor
- The University of Hong Kong
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-04
- Primary completion
- 2023-08-28
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.